
Celltrion Opens UK Headquarters in Uxbridge
Celltrion UK has officially opened its new UK headquarters at the Charter Building in Uxbridge, UK.
Celltrion UK has officially opened its new UK headquarters at the Charter Building in Uxbridge, UK.
The Innovation Center will focus on research and development for sustainable drilling and completion, production, and stimulation processes, and will also serve as a platform for workshops and training sessions.
Neoenergia began construction of one of the first green hydrogen (H2V) power plants Brazil, located in Taguatinga with an investment of more than R$ 30 million (€ 4.7 million).
BASF has opened a new Good Manufacturing Practice (GMP) Solution Center in Wyandotte, Michigan, to support the supply of bioprocessing ingredients and excipients for the biopharma and pharmaceutical industries.
BASF has announced the successful startup of its new world-scale hexamethylenediamine (HMD) plant in Chalampé, France, construction of which began in 2022.
Syensqo, a global company specializing in advanced materials and specialty chemicals, has announced the opening of new microbiology, (eco-)toxicology, and biotechnology laboratories in Lyon, France.
Schott Pharma is investing more than €100 million in its existing site in Lukácsháza, Hungary, to expand its capacity for sterile ready-to-use (RTU) cartridges.
DuPont announced that it has expanded its sterile operations via an addition to its healthcare manufacturing facility in Heredia, Costa Rica.
Curia, a CDMO, recently shared expansion plans for facilities in Glasgow, UK, and Albuquerque, NM, US.
Nova Chemicals commissions its first polyethylene (PE) film mechanical recycling facility in Connersville, IN, US.
Siegfried announced a further expansion of its ophthalmic drug manufacturing site in El Masnou near Barcelona, Spain.
The Swiss peptide and oligonucleotide manufacturers roll out major investments across site networks in US, UK, and Switzerland
Ecolab Life Sciences has officially opened its new US Bioprocessing Applications Laboratory in Pennsylvania.
Gelest, a Mitsubishi Chemical Group company, announced the opening of its new production facility in the US.
Bristol Myers Squibb appoints Cari Gallman as EVP and invests $40 billion in the US over 5 years.
Perstorp and BRB, subsidiaries of Petronas Chemicals Group (PCG), inaugurated an innovation hub in Shanghai, China. The laboratory will support growth in the region by increasing technical support for customers.
Merck Wilmington Biotech will serve as a launch and commercial production facility and the future US home for Keytruda.
Roche recently announced that it will invest $50 billion (€43.8 billion) into the United States in the next five years.
Cellasto, the world leader in Noise, Vibration and Harshness (NVH) components, is investing roughly €60 million to establish a second plant in Shanghai, China.
To meet growing demand from the pharmaceutical industry, Asahi Kasei has established Asahi Kasei Life Science to operate its bioprocess businesses under a new organizational structure.
Novo Nordisk continues its sizeable manufacturing investments to meet increasing drug demands.
Solvay has officially inaugurated its rare earths production line for permanent magnets at the La Rochelle facility, marking a significant milestone in the Group’s commitment to meeting Europe’s strategic goals.
NBE Therapeutics (NBE), a wholly owned subsidiary of Boehringer Ingelheim, officially opened its new ADC R&D facility in Basel.
New facility will focus on crosslinkers and binders, with the potential to test tens of thousands of formulations per year. Digitalization and automation enable data-driven research and development, while networked robotics allow more efficient data generation for segment-specific application testing.
Vynova Alkoxides GmbH is beginning the construction of a new alcoholates plant at Chemiepark Lülsdorf GmbH in Lülsdorf, Germany.
US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.
OMV has announced the expansion of its innovative ReOil technology at the Schwechat refinery near Vienna.
Britain’s AstraZeneca wants to invest $2.5 billion in Beijing, China to establish its sixth global strategic R&D center.
Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.
Syngene, a global contract research, development, and manufacturing organization (CRDMO), recently announced the acquisition of its first biologics site in the USA – fitted with multiple monoclonal antibody (mAbs) manufacturing lines.
Axplora, an API small molecule and ADC (antibody-drug conjugate) manufacturer, is strengthening its position in the commercial manufacturing ADCs by launching a cutting-edge payload manufacturing workshop at its Le Mans site (France).
German contract development and manufacturing organization (CDMO) Adragos Pharma has completed a €4 million project to install and commission a new, cGMP-compliant liquid drug filling line and associated cartoning machine at its plant in Leipzig, Germany.
Contract development and manufacturing organization (CDMO) CordenPharma has finalized plans to establish a new peptide manufacturing facility in Switzerland located at Getec Park in Muttenz near Basel. This investment is part of the company’s growth initiatives with a more than €1 billion strategic investment in peptide development and manufacturing.
Toray Industries has opened the Toray Taiwan Technical Center. This new facility aims to enhance research and development in advanced semiconductor technologies and materials, and provide technical services in the Taiwan market, which plays a significant role in the global semiconductor supply chain.
Eli Lilly plans to invest $27 billion to bolster its domestic medicine production across several therapeutic areas by building four new manufacturing sites in the US.